pharmaceutical investing La Jolla Pharmaceutical Company Gets European Commission Approval for GIAPREZA
pharmaceutical investing La Jolla Pharmaceutical Company Receives Orphan Designation from FDA for LJPC-0118
pharmaceutical investing La Jolla Pharmaceutical Company Announces U.S. FDA’s Grant of Breakthrough Therapy Designation for LJPC-0118
pharmaceutical investing La Jolla Pharmaceutical Company Announces European Medicines Agency Validation of Marketing Authorisation Application for GIAPREZA
LaFleur Minerals Closes LIFE, Flow Thru and Final Hard Dollar Offering for $900,000 to Complete Total of $7,800,421 Funding to Restart Beacon Gold Mill Production Operations in Abitibi Greenstone Belt
RZOLV Technologies Successfully Completes Bulk-Scale Vat Leach Test at Operating Gold Mine, Advancing Commercial Validation of RZOLV Non-Cyanide Gold Extraction
TERRA CLEAN PROVIDES CORPORATE UPDATE AND WELCOMES THE UNITED STATES DEPARTMENT OF ENERGY'S RECENT NEW DOMESTIC NUCLEAR FUEL SUPPLY CHAIN & URANIUM FOCUS
SAGA Metals Reports Strongest Critical Mineral Drill Results To-Date at Radar Ti-V-Fe Project in Labrador
